The Doctor’s Dilemma

“First, do no harm.” As we weigh the strategies for tackling the opioid epidemic, I have been asking myself how we, as physicians and educators, can best honor that primary ethical commitment in a situation where there are no easy answers. As a psychiatrist, I have seen well-managed pain medication bring immense relief to patients suffering from debilitating pain. But I have also seen lives destroyed by opioid abuse, addiction, and overdose. How do physicians find the right balance between providing treatment and preventing abuse?

The statistics are staggering. More Americans now die from overdoses every year than in motor vehicle crashes. A majority of these overdoses involve prescription medications. Heroin-related overdoses nearly doubled between 2011 and 2013, and four in five heroin users started out by misusing prescription pain medication. This has become a full-blown public health crisis. As health care anchors in their communities, America’s medical schools and teaching hospitals see the impact of this crisis every day.

In education, research, and care, academic medicine is constantly evolving to keep pace with public health challenges and meet the needs of patients and communities. Nowhere is this more evident than in the current opioid epidemic. Nationwide, medical schools are building on existing substance abuse and pain management content that is part of required and elective coursework at nearly all U.S. medical schools. Medical schools augment lectures with a variety of hands-on instructional methods, such as simulated patient exercises, case-based instruction, workshop assessments, and clinical experiences. This strategy of weaving content throughout all four years of medical school strengthens knowledge retention. As they move into residency training, learners continue to work directly with patients to treat pain and learn the best practices for safely prescribing pain medication, especially opioids.

Scroll to Top

Canada Post has provided notification of restarting their operations on December 17, 2024. As Canada Post ramps up and stabilizes their services, the BC-CfE will continue the following measures on an interim basis to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory will utilize private courier for delivery of outgoing reports and documents. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy will utilize private courier for delivery of medications. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)